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Abstract
Background—West Nile virus (WNV) infection is associated with acute morbidity and 
mortality in adults and children. Information on the effects of maternal WNV illness during 
pregnancy on early childhood development is limited. This study was designed to examine the 
relationship between maternal WNV illness during pregnancy and birth and developmental 
outcomes at age 3 years.
Methods—Mother-child participants were identified using a national surveillance registry for 
women with WNV illness during pregnancy. Maternal and infant health data and relevant family 
characteristics were obtained through medical record reviews and maternal questionnaires. All 
infants received ophthalmologic examinations. Child development was evaluated at age 3 years 
using the Bayley Scales of Infant and Toddler Development–Third Edition (Bayley-III).
Results—As a group, the children’s (N = 11) birth weight, head circumference, and infant 
ophthalmologic examination results were within age expectations; one child was born preterm 
(gestational age 36 weeks). Mean (SD) age at the time of Bayley-III testing was 36.7 (3.8) months. 
The group’s mean performance on the Bayley-III was at or above age level in all domains, but one 
child showed a mild delay in the Adaptive domain. The variability observed in this sample (1/53 
[1.9%] Domain scores < −2.0 SDs) was consistent with expectations based upon the distribution 
of Bayley-III Domain scores in the general population.
Conclusion—Maternal WNV infection does not appear to be associated with global 
developmental delays in young children. These results are preliminary, however, and require 
confirmation in future research.
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Introduction
West Nile virus (WNV) is a neurotropic virus transmitted primarily through infected 
mosquitoes but also by means of blood transfusion, organ transplantation, intrauterine 
exposure, and in laboratory settings (Hayes and O’Leary, 2004; Lindsey et al., 2010). 
Although the majority of individuals infected with WNV are asymptomatic, approximately 
20% develop WNV illness manifested by fever, headache, myalgias, and other nonspecific 
symptoms, and approximately 1% develop neuroinvasive disease such as meningitis, 
encephalitis, or acute flaccid paralysis (Petersen and Marfin, 2002; Hayes and O’Leary, 
2004; Hayes et al., 2005; Carson et al., 2006; O’Leary et al., 2006; Sejvar, 2007). According 
to the Centers for Disease Control and Prevention (CDC, 2013), the number of reported 
cases of WNV disease in the United States in 2012 was the highest since 2003, including 
2873 (51%) cases classified as neuroinvasive disease and 2801 classified as 
nonneuroinvasive disease. There were 2469 cases in 2013; as in 2012, half (51%) were 
classified as neuroinvasive disease (Lindsey et al., 2014).
The first case of congenitally acquired WNV was identified in 2002 (CDC, 2002; Alpert et 
al., 2003). The mother developed WNV encephalitis at 27 weeks of gestation. Her full-term 
newborn had laboratory evidence of WNV infection, chorioretinitis, and cystic destruction 
of cerebral tissue. Subsequently, the CDC established a national WNV Pregnancy Registry 
in 2003 and produced guidelines for evaluation of potentially infected newborns in 2004 
(CDC, 2004). Early analyses of registry data suggested that maternal WNV infection during 
pregnancy did not commonly cause adverse effects on fetal and newborn growth and 
development (O’Leary et al., 2006), although long-term outcomes were not evaluated.
Because WNV is neurotropic and able to cross the placental barrier, we hypothesized that 
prenatal exposure to WNV might increase the risk of developmental delay in young 
children. The purpose of the present study was to evaluate developmental outcomes of 
young children born to women enrolled in the CDC’s WNV Pregnancy Registry.
Materials and Methods
PARTICIPANTS
There were 72 live births in 2003 to 2004 among women enrolled in the registry (O’Leary et 
al., 2006). All of the infants were born to women with laboratory-confirmed WNV infection 
during their pregnancy. All of these mother-child pairs were considered eligible for 
participation in the study. The mothers were contacted by state or CDC WNV coordinators 
to request permission for telephone contact from a study investigator at Tulane University. If 
they agreed, the investigator called the mother to describe the purpose of the study, obtain 
oral consent to participate, and obtain an address to mail the written informed consent and 
maternal self-report questionnaire. The call was conducted using a scripted telephone 
interview. The study was approved by the Institutional Review Boards (IRBs) of Tulane 
University and the CDC.
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PROCEDURES
The present study used information available in the WNV registry, including information 
from mothers and health care providers about maternal and infant health at delivery and 
infant health at ages 2, 6, and 12 months. Evidence of maternal WNV infection was 
ascertained through IgM and IgG ELISA testing of maternal serum, cord blood, placental 
tissue, umbilical cord tissue, and breast milk obtained at the time of delivery. Follow-up 
testing of infant serum or cerebrospinal fluid was performed during infancy when clinically 
indicated (O’Leary et al., 2006). Ophthalmologic examinations were arranged for all infants.
Abstraction of infant and maternal medical records was performed by local physicians and 
nursing staff and recorded on study-specific data collection forms. For infants, the following 
information was obtained from physical examinations performed between birth and 42 
months of age: evidence of WNV infection (obtained from tests performed during infancy 
for the WNV Pregnancy Registry), date of birth, sex, gestational age, birth weight and 
length, head circumference, Apgar scores, temperature at birth, and presence of congenital 
abnormalities, chorioretinitis, skin rashes, pneumonia, seizures and other neurologic 
abnormalities, and any other illnesses present at birth and up to 42 months of age. Sex-
specific intrauterine growth curves (Olsen et al., 2010) were used to determine the 
appropriateness for gestational age of the infants’ birth weight and head circumference 
measurements. The following information was abstracted from the mothers’ medical 
records: trimester of infection with WNV, date of onset of symptoms, severity of 
symptomatic WNV illness (fever vs. neuroinvasive disease), maternal age at delivery, 
delivery method, temperature and clinical status at delivery, and history of maternal illness, 
complications of pregnancy, and fetal abnormalities.
The maternal self-report questionnaire was returned by mail to the Tulane investigator. It 
requested the following information: level of maternal education, occupation, race/ethnicity, 
marital status, household income, family history of birth defects, history of maternal illness 
during pregnancy, and history of use of medications, tobacco, and alcohol during pregnancy. 
Mothers also provided a general description of their perception of their infant’s health 
(sicker than average, average, or very healthy) and development (whether normal or above 
average).
The Bayley Scales of Infant and Toddler Development—Third Edition. (Bayley-III; Bayley, 
2006) were administered to children at approximately 3 years of age by local participating 
psychologists, using standardized assessment procedures. The evaluations were performed 
in local clinics or, in one case, in the child’s home. The Bayley-III provides standardized 
measures of child development in five domains: Cognitive (problem-solving), Language 
(receptive and expressive skills), Motor (fine- and gross-motor skills), Social-Emotional 
(social behavior and self-regulation), and Adaptive Behavior (for example, communication, 
self-care, and pre-academic skills). The Cognitive, Language, and Motor domains are 
assessed through direct testing with the child; the Social-Emotional and Adaptive Behavior 
domains are assessed through interviews with the parent. The standardization sample of the 
Bayley-III provides the reference mean for the Domain Composite scores (Mean = 100, 
standard deviation [SD] = 15).
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Results
The Tulane investigator received contact information for 61 women enrolled in the WNV 
Pregnancy Registry in 2003 to 2004. Of these, 15 agreed to participate with their children. 
Seven women declined to participate, and 39 were considered lost to follow-up because their 
state health department could not locate them. The investigators did not ask the women for 
their reasons for declining, per IRB guidelines, and study personnel did not have access to 
demographic or other data about the women and infants who did not participate. When 
compared with the original cohort (O’Leary et al., 2006), the subset of women who 
participated in this study were generally older and more predominantly white, non-Hispanic. 
Of the 15 children enrolled, 11 completed the Bayley-III. Four children missed the 
assessment due to lack of a qualified local examiner (n = 1), missed appointments (n = 1), 
and loss to follow-up (could not be located; n = 2).
The mean age of the 11 children at the time of the Bayley-III assessment was 36.7 (SD = 
3.8) months. According to infant IgM levels at the time of delivery, none of the children 
were congenitally infected with WNV. The study sample was too small for formal 
hypothesis testing; descriptive data are presented in Tables 1 and 2.
Relevant health and demographic characteristics of the mothers and children are shown in 
Table 1. One child was born preterm (gestational age 36 weeks). No child was born at low 
birth weight; all weighed more than 2500 g. Birth weights and head circumferences were 
appropriate for gestational age for all infants except two who were large for gestational age 
(above the 90th percentile), one in birth weight and the other in head circumference. The 
results of infant ophthalmologic examinations were within normal limits. Most (64%) of the 
mothers had at least a college degree, and 82% had annual household incomes greater than 
$40,000. Most (82%) of the mothers were infected with WNV during the second or third 
trimester. The mothers’ responses to the self-report questionnaire, completed 3 to 16 months 
before infant testing, indicated that 55% perceived their infants’ health as “average,” and 
64% perceived their infants’ overall development as “normal” (Table 1).
As a group, the children’s performance was at or above age level in all domains of the 
Bayley-III (Table 2). One child was in the mildly delayed range in the Adaptive Behavior 
domain but at age level on the Cognitive, Language, Motor, and Social-Emotional domains. 
The local examiner attributed this child’s lower Adaptive score to lack of environmental 
opportunity rather than to developmental delay. Most of the mothers in the study (n = 9; 
82%) had nonneuroinvasive WNV illness. Two mothers (18%) had meningitis, indicating 
the presence of neuroinvasive WNV disease; there was no evidence of developmental delay 
in their children’s performance on the Bayley-III.
Discussion
The findings of the present study were consistent with previous studies of infants born to 
women with WNV infection (O’Leary et al., 2006; Ornoy and Tenenbaum, 2006), indicating 
that maternal WNV illness during pregnancy does not commonly cause global 
developmental delay in young children. As a whole, the children in this study performed 
Sirois et al. Page 4
Birth Defects Res A Clin Mol Teratol. Author manuscript; available in PMC 2015 September 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
within age expectations in all developmental domains assessed at age 3 years. In addition, 
they were medically well at birth and at repeated follow-up examinations with their local 
medical providers during the first 3 years of life. One child demonstrated lower-than-
expected performance in one domain but did not show evidence of a global delay in 
development.
The strengths of this study include the long-term follow-up and standardized assessment of 
child development. This analysis provides additional information on development for a 
subset of infants previously described at age 12 months by O’Leary and colleagues (O’Leary 
et al., 2006). At an evaluation at 3 years of age, we did not find evidence of global 
developmental delay. The study was limited, however, by the small sample size, the lack of 
a comparison group (beyond the standardization sample of the Bayley-III), and the 
demographic homogeneity of the sample. Maternal education and family income are related 
to child development (Brooks-Gunn and Duncan, 1997; Bradley and Corwyn, 2002). It is 
possible that mothers who participated in the study had greater resources available to them 
than mothers who did not participate, and these resources may have protected the children 
from the potentially adverse effects of prenatal exposure to WNV. The study was also 
affected by logistical difficulties such as geographical distance to the study sites and limited 
access to qualified examiners for the Bayley-III assessment. These factors may have 
introduced a selection bias by increasing the burden of research participation for parents 
enrolled in the study and for those who chose not to enroll. We did not test infants for WNV 
infection after birth; it is possible that an infant’s results may have been influenced by WNV 
infection acquired between the time of delivery and the time the developmental assessments 
were performed.
To our knowledge, this study is the first of its kind, and the findings warrant confirmation in 
future research. Although the results were reassuring, the number of children we were able 
to evaluate, despite intensive effort, was small. A prospective study of infants born to 
women enrolled in the WNV Pregnancy Registry is underway. Data from the medical 
examinations and developmental assessments obtained in that study will provide additional 
information about the developmental outcomes of children born to mothers with WNV 
infection during pregnancy.
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TABLE 1
Health and Demographic Characteristics of Study Participants (N = 11).
Characteristic Mean (SD) or n (%)
Infant Gestational age (weeks) 38.3 (1.2)
Birth weight (g) 3200 (400)
Head circumference (cm) 35.0 (1.0)
Vaginal delivery 5 (45%)
Caesarean delivery 5 (45%)
Congenital abnormality presenta 4 (36%)
Age at Bayley-III assessment (months) 36.7 (3.8)
Maternal Age at delivery (years) 34.0 (4.7)
Education: college degree or higher 7 (64%)
Caucasian race/non-Hispanic ethnicity 11 (100%)
Trimester of infection: first, second, third 2 (18%), 5 (46%), 4 (36%)
Complications of pregnancy presentb 4 (36%)
Reported smoking during pregnancyc 0
Alcohol use during first 20 weeks of pregnancyc 2 (18%)
Household income above $40,000 per yeard 9 (82%)
Perception of infant’s health:
 Sicker than average 0 (0%)
 Average 6 (55%)
 Very healthy 5 (45%)
Perception of infant’s development:
 Normal 7 (64%)
 Above average 4 (36%)
a
Two women had a newborn with a major birth defect (cleft palate and aortic coarctation); however, both women were infected with WNV in the 
third trimester, presumably after the abnormality had developed.
bComplications reported by mothers’ physicians included hypertension, chorioamnionitis, severe yeast infection, and severe preeclampsia; none 
were considered likely to have had an adverse effect on the infants’ development.
c
Three women chose not to respond to this item.
dOne woman chose not to respond to this item.
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